SCHEMBL26630402

SCHEMBL26630402

C=CC(=O)Nc1ccc2c(cnn2C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ ALOX12 P18054 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ MAOB P27338 3/20 0.54
▸ MAOA P21397 2/20 0.54
▸ ACHE P22303 1/20 0.54
▸ NOTUM Q6P988 1/20 0.53
▸ NAMPT P43490 2/20 0.51
▸ FGFR1 P11362 2/20 0.48
▸ FGFR4 P22455 2/20 0.48
▸ TGM2 P21980 4/20 0.46
▸ EGFR P00533 1/20 0.46
▸ ITK Q08881 1/20 0.46
▸ CDC7 O00311 1/20 0.45
▸ TRPM5 Q9NZQ8 1/20 0.45
▸ MAPK1 P28482 1/20 0.44
▸ NOX1 Q9Y5S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30190722 0.86 JAK3 (0.51) NPC1ALDH1A1MAPTHPGDALOX12
SCHEMBL24150517 0.86 JAK3 (0.51) NPC1ALDH1A1MAPTHPGDALOX12
SCHEMBL16686040 0.82 NPC1 (0.63) NPC1ALDH1A1MAPTHPGDALOX12
SCHEMBL12518644 0.81 EGFR (0.75) EGFRITK
SCHEMBL30190875 0.79 JAK3 (0.51) FGFR1FGFR4ITKCCNCCDK8
SCHEMBL24150191 0.79 JAK3 (0.51) FGFR1FGFR4ITKCCNCCDK8
SCHEMBL25597800 0.77 HTR2B (0.54) NPC1MAPTRAB9AMAOBNOTUM
SCHEMBL4922780 0.77 MAOB (0.59) NPC1ALDH1A1MAPTHPGDALOX12
SCHEMBL31036105 0.77 NOTUM (0.61) NPC1ALDH1A1MAPTHPGDALOX12
SCHEMBL29510910 0.77 NPC1 (0.78) NPC1ALDH1A1MAPTHPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282735-A1 BICYCLE COMPOUNDS AS TEAD INHIBITOR DONG-A ST CO., LTD. (KR) 2025-09-11 — — US disclosed
EP-4514780-A1 BICYCLE COMPOUNDS AS TEAD INHIBITOR Dong-A ST Co., Ltd. (KR) 2025-03-05 — — EP disclosed
WO-2023209651-A1 BICYCLE COMPOUNDS AS TEAD INHIBITOR DONG-A ST CO., LTD. (KR) 2023-11-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282735-A1 BICYCLE COMPOUNDS AS TEAD INHIBITOR TEAD1, TEAD2, TEAD3 NPC1 602/4885ALDH1A1 649/4885MAPT 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback